A randomized, double-blind, placebo-controlled, phase II clinical trial to investigate the efficacy and safety of oral DA-1229 in patients with type 2 diabetes mellitus who have inadequate glycaemic control with diet and exercise. (Q36349300)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized, double-blind, placebo-controlled, phase II clinical trial to investigate the efficacy and safety of oral DA-1229 in patients with type 2 diabetes mellitus who have inadequate glycaemic control with diet and exercise. |
scientific article |
Statements
A randomized, double-blind, placebo-controlled, phase II clinical trial to investigate the efficacy and safety of oral DA-1229 in patients with type 2 diabetes mellitus who have inadequate glycaemic control with diet and exercise (English)
Chang Hee Jung
Cheol-Young Park
Kyu-Joeng Ahn
Nan-Hee Kim
Hak-Chul Jang
Moon-Kyu Lee
Joong-Yeol Park
Kyung-Wan Min
Yeon-Ah Sung
Jeong-Hyun Park
Sung Jin Kim
Hyo Jung Lee
Sung-Woo Park
5 December 2014
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference